Your browser doesn't support javascript.
loading
Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetes.
Kobayashi, Hiroki; Looker, Helen C; Satake, Eiichiro; D'Addio, Francesca; Wilson, Jonathan M; Saulnier, Pierre Jean; Md Dom, Zaipul I; O'Neil, Kristina; Ihara, Katsuhito; Krolewski, Bozena; Badger, Hannah S; Petrazzuolo, Adriana; Corradi, Domenico; Galecki, Andrzej; Wilson, Parker C; Najafian, Behzad; Mauer, Michael; Niewczas, Monika A; Doria, Alessandro; Humphreys, Benjamin D; Duffin, Kevin L; Fiorina, Paolo; Nelson, Robert G; Krolewski, Andrzej S.
Affiliation
  • Kobayashi H; Section on Genetics and Epidemiology, Research Division, Joslin Diabetes Center, Boston, MA 02215, USA.
  • Looker HC; Department of Medicine, Harvard Medical School, Boston, MA 02215, USA.
  • Satake E; Division of Nephrology, Hypertension, and Endocrinology, Nihon University School of Medicine, Tokyo 173-8610, Japan.
  • D'Addio F; Chronic Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, AZ 85014, USA.
  • Wilson JM; Section on Genetics and Epidemiology, Research Division, Joslin Diabetes Center, Boston, MA 02215, USA.
  • Saulnier PJ; Department of Medicine, Harvard Medical School, Boston, MA 02215, USA.
  • Md Dom ZI; Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, DIBIC L. Sacco, Università di Milano and Endocrinology Division ASST Sacco-FBF, Milan 20121, Italy.
  • O'Neil K; Diabetes and Complications Department, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46225, USA.
  • Ihara K; Chronic Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, AZ 85014, USA.
  • Krolewski B; CHU Poitiers, University of Poitiers, Inserm, Clinical Investigation Center CIC1402, Poitiers 86000, France.
  • Badger HS; Section on Genetics and Epidemiology, Research Division, Joslin Diabetes Center, Boston, MA 02215, USA.
  • Petrazzuolo A; Department of Medicine, Harvard Medical School, Boston, MA 02215, USA.
  • Corradi D; Section on Genetics and Epidemiology, Research Division, Joslin Diabetes Center, Boston, MA 02215, USA.
  • Galecki A; Section on Genetics and Epidemiology, Research Division, Joslin Diabetes Center, Boston, MA 02215, USA.
  • Wilson PC; Department of Medicine, Harvard Medical School, Boston, MA 02215, USA.
  • Najafian B; Section on Genetics and Epidemiology, Research Division, Joslin Diabetes Center, Boston, MA 02215, USA.
  • Mauer M; Department of Medicine, Harvard Medical School, Boston, MA 02215, USA.
  • Niewczas MA; Diabetes and Complications Department, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46225, USA.
  • Doria A; Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, DIBIC L. Sacco, Università di Milano and Endocrinology Division ASST Sacco-FBF, Milan 20121, Italy.
  • Humphreys BD; Department of Medicine and Surgery, Unit of Pathology, University of Parma, Parma 43126, Italy.
  • Duffin KL; Department of Internal Medicine, Medical School, University of Michigan, Ann Arbor, MI 48109, USA.
  • Fiorina P; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI 48109-2029, USA.
  • Nelson RG; Division of Anatomic and Molecular Pathology, Department of Pathology and Immunology, Washington University in Saint Louis School of Medicine, St. Louis 63110, USA.
  • Krolewski AS; Department of Laboratory Medicine & Pathology, University of Washington, Seattle, WA 98109, USA.
Sci Transl Med ; 14(657): eabj2109, 2022 08 10.
Article in En | MEDLINE | ID: mdl-35947673

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cell Cycle Proteins / Diabetes Mellitus, Type 2 / Kidney Failure, Chronic / Neuroblastoma Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Sci Transl Med Journal subject: CIENCIA / MEDICINA Year: 2022 Document type: Article Affiliation country: United States Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cell Cycle Proteins / Diabetes Mellitus, Type 2 / Kidney Failure, Chronic / Neuroblastoma Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Sci Transl Med Journal subject: CIENCIA / MEDICINA Year: 2022 Document type: Article Affiliation country: United States Country of publication: United States